When does food suppression start on Mounjaro — and what should you expect?

The first fortnight: what you may notice before the scale moves

Picture this: it's a Tuesday evening, about ten days after your first injection, and you realise you've left half a plate of pasta and genuinely don't want the rest. That moment, small as it sounds, is often the first tangible sign that Mounjaro is doing something. Tirzepatide starts activating GIP and GLP-1 receptors from the moment it enters your system, slowing how quickly food leaves your stomach and adjusting the hunger and fullness signals your brain receives. The appetite-suppressing mechanism is not a switch that flips on a fixed day; it is a gradual recalibration.

The 2.5 mg starting dose is deliberately modest. Its primary job is to help your body adjust without triggering intense nausea, not to deliver maximum appetite suppression. Even so, a meaningful number of people report eating less and feeling full sooner within the first two weeks. Others notice almost nothing at this stage, and that is equally within the expected range. The NHS tirzepatide information page confirms that the starter dose is a tolerability step on the way to therapeutic doses, so if week one feels underwhelming, the programme is still working as intended.

Side effects, particularly nausea and indigestion, are most likely during this early period. Paradoxically, these can make eating less feel more like a side effect than an appetite benefit. The distinction matters for managing your expectations: genuine appetite suppression is a quieter experience (less urgency, smaller portions, food losing some of its pull) rather than simply feeling too unwell to eat.

Weeks four to twelve: as the dose climbs, so does the effect

For most people, the clearest change in appetite arrives not at 2.5 mg but at 5 mg or beyond, typically around weeks four to twelve of treatment. Each time the prescriber moves you to the next strength, there is usually a renewed and often stronger reduction in hunger in the days that follow. This is the compounding nature of tirzepatide: its half-life means it accumulates in your system over several weeks, and each dose step builds on that foundation.

The experience tends to shift from "I feel a bit less hungry" to something more structural: meals that would once have felt normal now feel too large, snacking urges quiet down noticeably, and the mental energy previously spent thinking about food decreases. Some people describe this as the treatment finally "clicking". Research from the SURMOUNT-1 trial, published in the New England Journal of Medicine, showed average body-weight reductions of around 20–21% at 15 mg over 72 weeks, outcomes that depend heavily on sustained appetite regulation across the full titration schedule. If you are curious whether the effect is working as expected for you, our overview of tirzepatide's appetite mechanisms goes into the receptor-level detail.

At this stage, what you eat alongside the suppression matters considerably. Protein and fibre become more important, not less, because smaller portions need to work harder. Our guide to eating well on Mounjaro covers the practical side of this.

When suppression seems to plateau or fade between doses

A common concern, particularly from week eight onwards, is the feeling that the appetite-suppressing effect drops off in the day or two before the next injection. This "end-of-week" dip is reported by many patients and is related to tirzepatide's pharmacokinetics: the medicine's concentration in your system is at its lowest just before the next dose. It does not mean the treatment is failing. It is a recognised pattern that often resolves or becomes less noticeable at higher doses, when the trough concentration is higher overall.

A separate scenario is the appetite effect seeming to plateau at a given dose even though the weekly injections continue on schedule. This, too, is common. The body adapts to a steady concentration of the medicine, and the dramatic early effect can settle into a more background level of suppression. For some people this means a dose review is worth discussing with their prescriber; for others, it reflects that the treatment is working in a steadier, sustainable way rather than the acute early signal. The detail on why suppression can change over time is worth reading if this feels familiar.

If you experience no appetite effect at all over several weeks, that is also worth raising. It is addressed separately in our piece on what to do when Mounjaro isn't suppressing appetite. The answer will usually involve a clinical conversation rather than simply waiting it out. You can find current treatment information and pricing on our Mounjaro prices page if you are weighing up starting or continuing privately.

What shapes how quickly the effect arrives for you personally

Several factors influence the timeline, and most of them are not things to "fix", they are simply your biology. Body composition, baseline metabolic rate, gut transit speed and individual receptor sensitivity all affect how quickly tirzepatide's suppression becomes perceptible. People who are more sensitive to GLP-1 receptor activity may notice changes within days; others experience a slower build over months.

Injection timing relative to meals is occasionally a factor too, though the injection can technically be given at any point in the week, keeping it consistent (same day, similar time) helps maintain steadier blood levels and may reduce the end-of-week dip. Food choices during titration also interact with how noticeable the suppression feels: eating slowly, prioritising protein and avoiding very large meals helps the fullness signals land more clearly.

Mounjaro is a prescription-only medicine assessed by a GPhC-registered prescriber, not a one-size course. The titration schedule, dose pauses and any adjustments are clinical decisions made on the basis of your individual response. If you want to talk through whether tirzepatide is right for your situation, a free consultation with our prescribers is the starting point. Check your eligibility and start your free consultation.